Last moves
Peptide Exchange
0molecules on your watchlist

Molecules

The screener

33 molecules. Sort any column, narrow by class or stage, or show only the ones you watch.

The screener lists every peptide medicine Peptide Exchange tracks, from phase 1 programmes to approved drugs. Stage is the furthest point reached for the use named on each molecule page; the last move column links to the most recent news item. Molecules join the board when a story about them is filed, so the list grows with the news.

Watch
Efpeglenatide Hanmi Pharmaceutical Incretins weekly injection Approved ▲ 2 Nov 2026
Insulin icodec and semaglutideKyinsu Novo Nordisk Incretins weekly injection Approved ■ 30 Oct 2026
MazdutideIBI362 Innoventwith Lilly Incretins Weekly injection Approved ▲ 27 Jun 2025
Oral semaglutideWegovy pill Novo Nordisk Incretins daily pill Approved ▲ 2 Nov 2026
OrforglipronFoundayo Eli Lilly Incretins daily pill Approved ■ 31 Oct 2026
Semaglutide Novo Nordisk Incretins weekly injection Approved ■ 3 Nov 2026
Semaglutide generic Dr. Reddy's Laboratories Incretins weekly injection Approved ▼ 26 Oct 2026
TirzepatideMounjaro and Zepbound Eli Lilly Incretins weekly injection Approved ▲ 30 Oct 2026
Maridebart cafraglutideMariTide · AMG 133 Amgen Incretins Monthly injection Phase 3 ■ 26 Nov 2024
RetatrutideLY3437943 Eli Lilly Incretins weekly injection Phase 3 ■ 3 Nov 2026
SurvodutideBI 456906 Boehringer Ingelheimwith Zealand Incretins Weekly injection Phase 3 None yet
UBT251 The United Laboratories Internationalwith Novo Nordisk Incretins weekly injection Phase 3 ▲ 26 Oct 2026
CX11VCT220 Corxel Pharmaceuticalswith Vincentage Pharma Incretins daily pill Phase 2 ▲ 27 Oct 2026
MET-097i Pfizerfrom Metsera Incretins Monthly injection (target) Phase 2 ▲ 7 Nov 2025
PemvidutideALT-801 Altimmune Incretins Weekly injection Phase 2 ■ 26 Jun 2025
DW5324DW5324 Daewon Pharmaceutical Incretins oral formulation Phase 1 ■ 29 Oct 2026